Discipline
News, research analysis and evidence-based explanation. 20 stories in this section.
Taiwan's integrated screening-to-cure cascade offers a practical path toward the WHO's 2030 hepatitis C elimination target, as chronic HCV continues to affect an estimated 50 million people worldwide.
A correspondence in The Lancet argues that the NordICC trial's modest reductions in colorectal cancer incidence and mortality must be understood in the context of widespread colonoscopy use during the …
A new Lancet comment highlights that adolescents living with HIV face a substantial mortality gap compared with the general population, with only about 60% accessing antiretroviral therapy versus 78% overall. …
Researchers have identified a pattern of proteins in blood that could help forecast whether a person will age healthily, opening a potential path to earlier risk assessment and prevention.
An AI-assisted scoping review of open-access literature finds that code sharing for clinical prediction models is still uncommon and varies widely in quality and documentation.
A first-in-human clinical trial of optogenetic therapy in 10 patients with advanced retinitis pigmentosa found the treatment safe and linked it to improved light sensitivity and object-detection tasks, though functional …
A new biophysics study from ISTA and the Francis Crick Institute shows that irregular, disordered microenvironments around tumor cells promote detachment and metastasis, revealing a general physical principle that may …
MedGemma, a family of open vision-language foundation models built on Gemma 3, demonstrates advanced medical understanding across multiple imaging domains, outperforming similarly sized generative models while retaining general capabilities.
Mpox transmission persists in the United States, with public health officials emphasizing vaccination, symptom recognition and access to treatment as key tools to contain the virus.
Three scientists who developed optogenetics, a technique that uses light to control neurons, have been awarded the 2026 Nobel Prize in Physiology or Medicine. The method has transformed neuroscience research …
A study of 6.1 million people in 118 countries finds women report more pain than men at every site measured, with the steepest rise occurring before age 55 and the …
Health researchers in Canada are urging the country to adopt permanent standard time rather than permanent daylight saving time, warning that darker winter mornings could disrupt sleep and worsen mental …
Benemérita Universidad Autónoma de Puebla will convene the Second International Veterinary Microbiology Congress from October 13 to 15, featuring experts on rabies, zoonoses, antimicrobial resistance, and veterinary public health.
Researchers at Memorial Sloan Kettering Cancer Center have identified a signaling molecule called MEK that drives tumor-fighting T cells to exhaust their energy. In animal and laboratory studies, blocking MEK …
Karl Deisseroth, Peter Hegemann and Georg Nagel receive the 2026 Nobel Prize in Physiology or Medicine for developing optogenetics, a technique that uses light to control nerve cells and has …
A small clinical trial suggests a vitamin D analog may dismantle pancreatic cancer's protective shield, making tumors more susceptible to chemotherapy and immune attack, particularly in patients with high levels …
A small trial found that 82% of patients receiving high-dose niacin alongside standard glioblastoma treatment remained progression-free after six months, suggesting the vitamin may help revive immune cells suppressed by …
A safety scientist's claim that artificial intelligence could kill all humans within a decade raises questions about how medicine evaluates uncertain, high-stakes predictions.
Researchers propose that five distinct conditions, including long Covid, ME/CFS and PTSD, may disrupt the same immune, metabolic and cellular energy networks, potentially explaining overlapping symptoms and opening the door …
High-risk myelodysplastic syndrome stem cells rely heavily on the molecule NAD for energy, and disrupting that pathway selectively weakens the cancer-driving cells, pointing to a possible new treatment target.
